Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

13-valent pneumococcal conjugate vaccine (PCV13).

Jefferies JM, Macdonald E, Faust SN, Clarke SC.

Hum Vaccin. 2011 Oct;7(10):1012-8. doi: 10.4161/hv.7.10.16794. Epub 2011 Oct 1. Review.

PMID:
21941097
[PubMed - indexed for MEDLINE]
Free Article
2.

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.

Isaacman DJ, McIntosh ED, Reinert RR.

Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Review.

PMID:
19700359
[PubMed - indexed for MEDLINE]
Free Article
3.

Continued control of pneumococcal disease in the UK - the impact of vaccination.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

J Med Microbiol. 2011 Jan;60(Pt 1):1-8. doi: 10.1099/jmm.0.020016-0. Epub 2010 Oct 21. Review.

PMID:
20965923
[PubMed - indexed for MEDLINE]
Free Article
4.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

PMID:
22954038
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].

Duggan ST.

Drugs. 2010 Oct 22;70(15):1973-86. doi: 10.2165/11205110-000000000-00000. Review.

PMID:
20883054
[PubMed - indexed for MEDLINE]
6.

Global prevailing and emerging pediatric pneumococcal serotypes.

McIntosh ED, Reinert RR.

Expert Rev Vaccines. 2011 Jan;10(1):109-29. doi: 10.1586/erv.10.145. Review.

PMID:
21162625
[PubMed - indexed for MEDLINE]
7.

Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine.

Gruber WC, Scott DA, Emini EA.

Ann N Y Acad Sci. 2012 Aug;1263:15-26. doi: 10.1111/j.1749-6632.2012.06673.x. Epub 2012 Jul 25. Review.

PMID:
22830997
[PubMed - indexed for MEDLINE]
8.

Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.

McEllistrem MC, Nahm MH.

Clin Infect Dis. 2012 Nov 15;55(10):1379-86. doi: 10.1093/cid/cis691. Epub 2012 Aug 16. Review.

PMID:
22903767
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

PMID:
19366365
[PubMed - indexed for MEDLINE]
10.

13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents.

Plosker GL.

Paediatr Drugs. 2013 Oct;15(5):403-23. doi: 10.1007/s40272-013-0047-z. Review.

PMID:
24030738
[PubMed - indexed for MEDLINE]
11.

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Paradiso PR.

Clin Infect Dis. 2011 May;52(10):1241-7. doi: 10.1093/cid/cir142. Review.

PMID:
21507921
[PubMed - indexed for MEDLINE]
Free Article
12.

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.

Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T.

Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Review.

PMID:
24083785
[PubMed - indexed for MEDLINE]
13.

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine.

Dinleyici EC, Yargic ZA.

Expert Rev Vaccines. 2009 Aug;8(8):977-86. doi: 10.1586/erv.09.68. Review.

PMID:
19627181
[PubMed - indexed for MEDLINE]
14.

Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines.

Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, Durando P, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:211-6. doi: 10.4161/hv.7.0.14602. Review.

PMID:
21546795
[PubMed - indexed for MEDLINE]
Free Article
15.

Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.

Reinert R, Jacobs MR, Kaplan SL.

Vaccine. 2010 Jun 11;28(26):4249-59. doi: 10.1016/j.vaccine.2010.04.020. Epub 2010 Apr 21. Review.

PMID:
20416266
[PubMed - indexed for MEDLINE]
16.

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.

Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC.

Vaccine. 2012 May 21;30(24):3503-14. doi: 10.1016/j.vaccine.2012.03.066. Epub 2012 Apr 1. Review.

PMID:
22475858
[PubMed - indexed for MEDLINE]
17.

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines.

Falup-Pecurariu O.

Biomed J. 2012 Nov-Dec;35(6):450-6. doi: 10.4103/2319-4170.104409. Review.

PMID:
23442357
[PubMed - indexed for MEDLINE]
Free Article
18.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
[PubMed - indexed for MEDLINE]
19.

Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults.

Grabenstein JD, Musey LK.

Vaccine. 2014 May 1;32(21):2399-405. doi: 10.1016/j.vaccine.2014.02.096. Epub 2014 Mar 14. Review.

PMID:
24637174
[PubMed - indexed for MEDLINE]
20.

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

Oosterhuis-Kafeja F, Beutels P, Van Damme P.

Vaccine. 2007 Mar 8;25(12):2194-212. Epub 2006 Dec 4. Review.

PMID:
17267077
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk